Encik Sasha Omar Firdaus bin Aamir Nordin (Encik Sasha) was appointed as the Chief Executive Officer (CEO) on 23 September 2020. Prior to his appointment as CEO of the Company, he was the Chief Operating Officer of the Company since 1 February 2014. Prior to joining the Company, he was employed at Neuramatix Sdn Bhd, the previous ultimate holding company of Malaysian Genomics Resource Centre Berhad, for a period of 13 years. Encik Sasha has extensive experience in business development, project planning and management, product development and strategic marketing. He has contributed to the growth of the Company including sourcing of grant and public funds for research and development, maintaining communications with strategic stakeholders and strategic planning.
Interest
He has 86,100 ordinary shares which represent approximately 0.063% of the total issued share capital of the Company (137,210,480 ordinary shares) as of todate.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....